Welcome
Support Centre
21 March 2013 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
A new beginning in life for young adults with poorly controlled type 1 diabetes
ISRCTN ISRCTN70566290
DOI 10.1186/ISRCTN70566290
ClinicalTrials.gov identifier
EudraCT number
Public title A new beginning in life for young adults with poorly controlled type 1 diabetes
Scientific title Guided self-determination tested in a flexible program for young adults with poorly controlled type 1 diabetes: a randomised controlled trial
Acronym N/A
Serial number at source N/A
Study hypothesis It is hypothesised that attending in a group based or individual course using Guided Self-determination (GSD) will improve the way young adults with poorly controlled type 1 diabetes live with their illness. The null hypothesis of no difference will be rejected if participants in the intervention group compared to those in a control group have decreased their HbA1c and improved their psychosocial functioning 18 months after the intervention.
Lay summary Background and study aims:
Being young and having to face a life with a chronic condition is a great challenge. In diabetes care more than half of the patients with type 1 diabetes live with poor glycaemic control which can lead to increased risk of diabetes related complications and poor quality of life. This study investigates patients’ own judgement of their situation and the problems connected with diabetes self-management.

Who can participate?
Young adults aged 18-35 years old, who have had type 1 diabetes for at least 1 year.

What does the study involve?
Participants are randomly distributed to having GSD immediately or 18 months delayed. They choose whether the course should have an individual or a group based form. Patients fill in reflection sheets before each appointment and talk with GSD-trained nurses about the issues they have written or drawn on the sheets. Through this process the young adults discover new aspects of their own way of living with the illness and also a new potential for managing diabetes in daily life. The nurses also discover new aspects in each patient’s life and thereby become able to support patients in finding their own way in managing the situation.

What are the possible benefits and risks of participating?
Participants will benefit from the course by learning to better control their diabetes. There are no known risks associated with taking part in this study.

Where is the study run from?
Steno Diabetes Center, Denmark

When is the study starting and how long is it expected to run for?
The study started n March 2010 and is due to end in September 2013.

Who is funding the study?
Steno Diabetes Center, Denmark
Danish National Board of Health, Denmark
Novo Nordisk - Department of Global Health, Denmark

Who is the main contact?
Vibeke Zoffmann
vzof@steno.dk
Ethics approval The National Committee on Health Research Ethics ref: H-D-2009-Fsp-29
The Danish Data Protection Agency ref: 2010-41-5448
Study design Randomized controlled trial a waitlist design
Countries of recruitment Denmark
Disease/condition/study domain Type 1 diabetes in poor control
Participants - inclusion criteria 1. Young adults, 18-35 years old with duration of type 1 diabetes at least 1 year
2. HbA1c at least 8.0% and mean HbA1c during the past 1-2 years at least 7.5%
Participants - exclusion criteria Young adults who due to mental or physical state and language barriers are unable to read and reflect on the reflection sheets used in GSD
Anticipated start date 01/03/2010
Anticipated end date 30/09/2013
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 200
Interventions Participants are by chance distributed 2:1 to having GSD immediately or 18 months delayed. They choose whether the course should have an individual form (eight 1-hour sessions in day time) or a group based form (eight 2½-hour sessions late afternoon). Patients fill in reflection sheets before each appointment and talk with GSD-trained nurses about the issues they have written or drawn on the sheets. Through this process the young adults discover new aspects of their own way of living with the illness and also a new potential for managing diabetes in daily life. The nurses also discover new aspects in each patient’s life and thereby become able to support patients in finding their own way in managing the situation. As part of GSD, advantages and disadvantages of different levels of HbA1c are also translated to patients in a meaningful way allowing patients to take autonomous decisions about their own goals which consequently in higher degree will be self-concordant.
Primary outcome measure(s) HbA1c
Secondary outcome measure(s) 1. Health Care Climate Questionnaire (HCCQ)
2. Treatment Self Regulation Questionnaire (TSRQ)
3. Problem Areas In Diabetes (PAID)
4. Perceived Competence with diabetes (PCD)
5. WHO-5
6. Rosenberg’s self-esteem scale (RSES)
7. Self-monitored blood-glucoses (SMBG) per week
8.Cancellations or failures to show-up
9. Type and amount of insulin treatment.
Sources of funding Steno Diabetes Center [Kliniske udviklingsmidler] (Denmark)
Danish national Board of Health (Denmark) ref: 7-203-02-434/5
Novo Nordisk Department of Global Health (Denmark)
Trial website
Publications
Contact name Dr  Vibeke  Zoffmann
  Address Steno Diabetes Center
Jellerød Have 32
  City/town Kokkedal
  Zip/Postcode 2980
  Country Denmark
Sponsor Steno Diabetes Center (Denmark)
  Address Niels Steensens vej 2
  City/town Gentofte
  Zip/Postcode 2820
  Country Denmark
  Sponsor website: http://www.steno.dk/documents/home_page/document/index.asp
Date applied 02/12/2012
Last edited 12/12/2012
Date ISRCTN assigned 12/12/2012
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2013 ISRCTN unless otherwise stated.